The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Default user image.

Gustav Smith

Associate professor

Default user image.

Concomitant use of warfarin and ticagrelor as an alternative to triple antithrombotic therapy after an acute coronary syndrome.

Author

  • Oscar Braun
  • Besim Bico
  • Uzma Chaudhry
  • Henrik Wagner
  • Sasha Koul
  • Patrik Tydén
  • Fredrik Scherstén
  • Stefan Jovinge
  • Peter Svensson
  • Gustav Smith
  • Jesper vanderPals

Summary, in English

Treatment with warfarin in combination with clopidogrel has been shown to reduce the incidence of major bleeding as compared to triple antithrombotic therapy (TT; warfarin, clopidogrel and aspirin). However, there are uncertainties regarding the risk for thrombosis since poor-responsiveness to clopidogrel is common. Ticagrelor is a more potent platelet inhibitor, but data supporting concurrent use of ticagrelor and warfarin (dual antithrombotic therapy, DT) is limited. This study therefore sought to evaluate the risk of bleeding and thrombosis associated with DT after an acute coronary syndrome (ACS).

Department/s

  • Cardiology
  • Cardiovascular Research - Epidemiology
  • Stem Cell Center
  • Clinical Coagulation, Malmö
  • Arrhytmias and Cardiac Device treatment
  • Molecular Cardiology
  • EXODIAB: Excellence of Diabetes Research in Sweden
  • EpiHealth: Epidemiology for Health

Publishing year

2015

Language

English

Pages

26-30

Publication/Series

Thrombosis Research

Volume

135

Issue

1

Document type

Journal article

Publisher

Elsevier Ltd

Topic

  • Cardiac and Cardiovascular Systems

Status

Published

Research group

  • Cardiovascular Research - Epidemiology
  • Clinical Coagulation, Malmö
  • Arrhytmias and Cardiac Device treatment
  • Molecular Cardiology

ISBN/ISSN/Other

  • ISSN: 1879-2472